APP and early-onset autosomal dominant Alzheimer disease: Although the amyloidogenic APP processing pathway has recently been targeted in patients with Alzheimer’s disease, the physiological role of APP/Aβ remains unclear, which limits our understanding of how such interventions could influence brain functions in health and disease.